225 related articles for article (PubMed ID: 10194125)
21. Widespread clonal B-cell disorder in Sjögren's syndrome predisposing to Helicobacter pylori-related gastric lymphoma.
De Vita S; Ferraccioli G; Avellini C; Sorrentino D; Dolcetti R; Di Loreto C; Bartoli E; Boiocchi M; Beltrami CA
Gastroenterology; 1996 Jun; 110(6):1969-74. PubMed ID: 8964425
[TBL] [Abstract][Full Text] [Related]
22. Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome.
Nocturne G; Virone A; Ng WF; Le Guern V; Hachulla E; Cornec D; Daien C; Vittecoq O; Bienvenu B; Marcelli C; Wendling D; Amoura Z; Dhote R; Lavigne C; Fior R; Gottenberg JE; Seror R; Mariette X
Arthritis Rheumatol; 2016 Apr; 68(4):977-85. PubMed ID: 26606524
[TBL] [Abstract][Full Text] [Related]
23. [The relationship between Sjogren's syndrome, systemic sclerosis and lymphoproliferative diseases].
Vasil'ev VI; Chal'tsev BD; Gorodetskii VR; Pal'shina SG; Shornikova NS; Anan'eva LP; Gaiduk IV; Kokosadze NV; Probatova NA; Pavlovskaia AI; Rodionova EB; Safonova TN; Balabina AA
Ter Arkh; 2020 Dec; 92(12):126-136. PubMed ID: 33720584
[TBL] [Abstract][Full Text] [Related]
24. [Sjögren's syndrome associated with non-Hodgkin's lymphoma].
Nagai K
Nihon Rinsho; 1995 Oct; 53(10):2574-9. PubMed ID: 8531376
[TBL] [Abstract][Full Text] [Related]
25. Lymphoproliferative disorders in Japanese patients with Sjögren's syndrome.
Sugai S; Shimizu S; Konda S
Scand J Rheumatol Suppl; 1986; 61():118-22. PubMed ID: 3473620
[TBL] [Abstract][Full Text] [Related]
26. Viral genomes in lymphomas of patients with Sjögren's syndrome.
Fox RI; Saito I; Chan EK; Josephs S; Salahuddin SZ; Ahlashi DV; Staal FW; Gallo R; Pei-Ping H; Le CS
J Autoimmun; 1989 Aug; 2(4):449-55. PubMed ID: 2571338
[TBL] [Abstract][Full Text] [Related]
27. Lymphoma in Sjogren's syndrome.
Pavlidis NA; Drosos AA; Papadimitriou C; Talal N; Moutsopoulos HM
Med Pediatr Oncol; 1992; 20(4):279-83. PubMed ID: 1608349
[TBL] [Abstract][Full Text] [Related]
28. Sjögren Syndrome-associated lymphomas: an update on pathogenesis and management.
Nocturne G; Mariette X
Br J Haematol; 2015 Feb; 168(3):317-27. PubMed ID: 25316606
[TBL] [Abstract][Full Text] [Related]
29. Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients.
Voulgarelis M; Skopouli FN
Clin Rev Allergy Immunol; 2007 Jun; 32(3):265-74. PubMed ID: 17992593
[TBL] [Abstract][Full Text] [Related]
30. Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma.
Andonopoulos AP; Tiniakou M; Melachrinou M; Sfountouris H; Bounas A; Zervas C; Zoumbos NC
Rev Rhum Engl Ed; 1997 May; 64(5):287-92. PubMed ID: 9190001
[TBL] [Abstract][Full Text] [Related]
31. Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients.
Papageorgiou A; Ziogas DC; Mavragani CP; Zintzaras E; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
PLoS One; 2015; 10(2):e0116189. PubMed ID: 25723713
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus study in malignant lymphoma in Sjögren's syndrome.
Hirose Y; Sugai S; Masaki Y; Ogawa Y; Takeshita S; Kin C; Ogawa N
Int J Hematol; 1999 Apr; 69(3):174-9. PubMed ID: 10222656
[TBL] [Abstract][Full Text] [Related]
33. B-cell lymphoproliferation in primary Sjögren's syndrome.
Tzioufas AG
Clin Exp Rheumatol; 1996; 14 Suppl 14():S65-70. PubMed ID: 8722203
[TBL] [Abstract][Full Text] [Related]
34. Salivary Gland Mucosa-Associated Lymphoid Tissue-Type Lymphoma From Sjögren's Syndrome Patients in the Majority Express Rheumatoid Factors Affinity-Selected for IgG.
Bende RJ; Janssen J; Beentjes A; Wormhoudt TAM; Wagner K; Haacke EA; Kroese FGM; Guikema JEJ; van Noesel CJM
Arthritis Rheumatol; 2020 Aug; 72(8):1330-1340. PubMed ID: 32182401
[TBL] [Abstract][Full Text] [Related]
35. Lymphoproliferative disorders in Sjögren's syndrome.
Masaki Y; Sugai S
Autoimmun Rev; 2004 Mar; 3(3):175-82. PubMed ID: 15110228
[TBL] [Abstract][Full Text] [Related]
36. Molecular B-cell clonality assay in minor salivary glands as a useful tool for the lymphoma risk assessment in Sjögren's syndrome.
Benyamine A; Poulet A; Belenotti P; Nihous H; Ene N; Jarrot PA; Swiader L; Mancini J; Beaufils N; Essaydi A; Gabert J; Weiller PJ; Kaplanski G
Joint Bone Spine; 2024 May; 91(3):105686. PubMed ID: 38161050
[TBL] [Abstract][Full Text] [Related]
37. Predictive markers of lymphomagenesis in Sjögren's syndrome: From clinical data to molecular stratification.
Kapsogeorgou EK; Voulgarelis M; Tzioufas AG
J Autoimmun; 2019 Nov; 104():102316. PubMed ID: 31431317
[TBL] [Abstract][Full Text] [Related]
38. The P2X7 receptor-NLRP3 inflammasome complex predicts the development of non-Hodgkin's lymphoma in Sjogren's syndrome: a prospective, observational, single-centre study.
Baldini C; Santini E; Rossi C; Donati V; Solini A
J Intern Med; 2017 Aug; 282(2):175-186. PubMed ID: 28503820
[TBL] [Abstract][Full Text] [Related]
39. [Characteristics of patients with primary Sjögren's syndrome and non-Hodgkin's lymphoma: analysis of 9 cases].
Jia N; Tang FL
Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(39):2786-8. PubMed ID: 20137605
[TBL] [Abstract][Full Text] [Related]
40. Lymphoma development in Sjögren's syndrome: novel p53 mutations.
Tapinos NI; Polihronis M; Moutsopoulos HM
Arthritis Rheum; 1999 Jul; 42(7):1466-72. PubMed ID: 10403275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
